Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

More salt is better: a novel management approach to acute decompensated heart failure.

Sica DA, Shah KB.

J Card Fail. 2014 May;20(5):302-3. doi: 10.1016/j.cardfail.2014.02.003. Epub 2014 Feb 12. No abstract available.

PMID:
24530321
2.

Intravenous salt supplementation with low-dose furosemide for treatment of acute decompensated heart failure.

Okuhara Y, Hirotani S, Naito Y, Nakabo A, Iwasaku T, Eguchi A, Morisawa D, Ando T, Sawada H, Manabe E, Masuyama T.

J Card Fail. 2014 May;20(5):295-301. doi: 10.1016/j.cardfail.2014.01.012. Epub 2014 Jan 22.

PMID:
24462960
3.

Continuous versus intermittent infusion of furosemide in acute decompensated heart failure.

Thomson MR, Nappi JM, Dunn SP, Hollis IB, Rodgers JE, Van Bakel AB.

J Card Fail. 2010 Mar;16(3):188-93. doi: 10.1016/j.cardfail.2009.11.005. Epub 2010 Jan 6.

PMID:
20206891
4.

Optimal decongestive therapy in acute decompensated heart failure syndromes: far from being solved.

Núñez J, Núñez E, Bodí V, Bayés-Genís A, Sanchis J.

Int J Cardiol. 2014 Jun 15;174(2):457-8. doi: 10.1016/j.ijcard.2014.04.015. Epub 2014 Apr 12. No abstract available.

PMID:
24767134
5.

Furosemide in acute decompensated heart failure.

[No authors listed]

Prescrire Int. 2012 Dec;21(133):303.

PMID:
23373103
6.

Acute decompensated heart failure.

Smithline HA.

CMAJ. 2007 Jul 17;177(2):175; author reply 175-6. No abstract available.

7.

Intravenous furosemide in decompensated heart failure: do not protocolize dosing but the desired effect!

de Grooth HJ, Girbes AR, Tuinman PR.

Crit Care. 2014 Dec 22;18(6):709. doi: 10.1186/s13054-014-0709-4. No abstract available.

8.

Continuous infusion of furosemide combined with low-dose dopamine compared to intermittent boluses in acutely decompensated heart failure is less nephrotoxic and carries a lower readmission at thirty days.

Aziz EF, Alviar CL, Herzog E, Cordova JP, Bastawrose JH, Pamidimukala CK, Tojino A, Park TS, Musat D, Kukin M.

Hellenic J Cardiol. 2011 May-Jun;52(3):227-35.

9.

Impact of intravenous loop diuretics on outcomes of patients hospitalized with acute decompensated heart failure: insights from the ADHERE registry.

Peacock WF, Costanzo MR, De Marco T, Lopatin M, Wynne J, Mills RM, Emerman CL; ADHERE Scientific Advisory Committee and Investigators.

Cardiology. 2009;113(1):12-9. doi: 10.1159/000164149. Epub 2008 Oct 17.

PMID:
18931492
10.

Loop diuretic strategies in patients with acute decompensated heart failure: a meta-analysis of randomized controlled trials.

Wu MY, Chang NC, Su CL, Hsu YH, Chen TW, Lin YF, Wu CH, Tam KW.

J Crit Care. 2014 Feb;29(1):2-9. doi: 10.1016/j.jcrc.2013.10.009. Epub 2013 Oct 29. Review.

PMID:
24331943
11.

Changes in natriuretic peptide and cytokine plasma levels in patients with heart failure, after treatment with high dose of furosemide plus hypertonic saline solution (HSS) and after a saline loading.

Tuttolomondo A, Pinto A, Di Raimondo D, Corrao S, Di Sciacca R, Scaglione R, Caruso C, Licata G.

Nutr Metab Cardiovasc Dis. 2011 May;21(5):372-9. doi: 10.1016/j.numecd.2009.10.014. Epub 2010 Mar 25.

PMID:
20346637
12.

A randomized, controlled trial of the renal effects of ultrafiltration as compared to furosemide in patients with acute decompensated heart failure.

Rogers HL, Marshall J, Bock J, Dowling TC, Feller E, Robinson S, Gottlieb SS.

J Card Fail. 2008 Feb;14(1):1-5. doi: 10.1016/j.cardfail.2007.09.007.

PMID:
18226766
13.

Improvement of glomerular filtration rate (GFR) and renal plasma flow (RPF) by stimultaneous administration of furosemide and salt in chronic renal failure.

Sharma B, Schuster G, Quintanilla A, Levin NW.

J Lab Clin Med. 1971 Dec;78(6):1018-9. No abstract available.

PMID:
5131852
14.

[Treatment of arterial hypertension using high doses of salt and furosemide].

del Rio Vazquez A, Carrera Carbo F.

Rev Clin Esp. 1975 Dec 31;139(6):553-7. Spanish. No abstract available.

PMID:
1215598
15.

Diuretic dosing in acute decompensated heart failure: lessons from DOSE.

Campbell PT, Ryan J.

Curr Heart Fail Rep. 2012 Sep;9(3):260-5. doi: 10.1007/s11897-012-0094-8. Review.

PMID:
22699924
16.

Efficacy and safety of high dose versus low dose furosemide with or without dopamine infusion: the Dopamine in Acute Decompensated Heart Failure II (DAD-HF II) trial.

Triposkiadis FK, Butler J, Karayannis G, Starling RC, Filippatos G, Wolski K, Parissis J, Parisis C, Rovithis D, Koutrakis K, Skoularigis J, Antoniou CK, Chrysohoou C, Pitsavos C, Stefanadis C, Nastas J, Tsaknakis T, Mantziari L, Giannakoulas G, Karvounis H, Kalogeropoulos AP, Giamouzis G.

Int J Cardiol. 2014 Mar 1;172(1):115-21. doi: 10.1016/j.ijcard.2013.12.276. Epub 2014 Jan 10.

PMID:
24485633
17.

Impact of dopamine infusion on renal function in hospitalized heart failure patients: results of the Dopamine in Acute Decompensated Heart Failure (DAD-HF) Trial.

Giamouzis G, Butler J, Starling RC, Karayannis G, Nastas J, Parisis C, Rovithis D, Economou D, Savvatis K, Kirlidis T, Tsaknakis T, Skoularigis J, Westermann D, Tschöpe C, Triposkiadis F.

J Card Fail. 2010 Dec;16(12):922-30. doi: 10.1016/j.cardfail.2010.07.246.

PMID:
21111980
18.

Absorption of high dose furosemide (frusemide) in congestive heart failure.

Van Meyel JJ, Gerlag PG, Smits P, Russel FG, Tan Y, Van Ginneken CA, Gribnau FW.

Clin Pharmacokinet. 1992 Apr;22(4):308-18.

PMID:
1606790
19.

Supplemental Content

Support Center